Hye Won Lee

Hye Won Lee

Auto-generated profile, based on publicly available information

Hye Won Lee

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Hepatology
Verified
Journal Article
Closed access
YSYu Shi
Yu Shi
RZRuoqi Zhou
Ruoqi Zhou
Seung Up KimSeung Up Kim
Seung Up Kim
Terry Cheuk-Fung YipTerry Cheuk-Fung Yip
Terry Cheuk-Fung Yip
ETEmmanuel Tsochatzis
Emmanuel Tsochatzis
OGon behalf of the VCTE-Prognosis Study Group
on behalf of the VCTE-Prognosis Study Group
Background and Aims: Weight control remains the cornerstone for metabolic dysfunction–associated steatotic liver disease (MASLD) management. We assessed the relationships between dynamic weight change and the risk of liver-related events (LREs) and liver stiffness changes in MASLD. Approach and Results: By enrolling adult MASLD individuals with ≥2 weight measurements from 16 tertiary referral centers, we assessed how longitude weight change, including the following categories (stable ≤5% change, weight loss >5% decrease, weight gain >5% increase) and changing status of obesity (persistent non-obesity, persistent obesity, transition from non-obesity to obesity, transition from obesity to non-obesity), were associated with LREs. Analyses were undertaken with multivariable linear regressions, Cox proportional hazards regression, and logistic regression, adjusting for age, sex, ethnicity, baseline BMI, hypertension, T2D, LSM, CAP, and SGLT-2i/GLP-1RAs usage. Analyses between weight change and liver stiffness change were also undertaken. A total of 10,014 MASLD individuals with ≥2 weight measurements were included. Over a measurement interval of 29.2 months, 123 LREs occurred during 12.4 months of follow-up after the final weight assessment. Weight gain >5% was associated with increased risk of LREs [aHR=1.84 (95% CI: 1.01–3.09), p =0.020] and liver stiffness progression [aOR=2.07 (95% CI: 1.55–2.74), p 5% exhibited liver stiffness improvement. Although those who progressed to or persisted with obesity had a higher LREs risk, obesity reversal had a comparable LREs risk [aHR=1.44 (95% CI: 0.57–3.61), p =0.435] to the persistent non-obese. Conclusions: In MASLD, weight gain is associated with increased LREs risks and liver stiffness progression. Conversely, weight loss confers benefits for liver stiffness improvement and modifies LREs risk in those who achieve obesity reversal.

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DKDarae Kim
Darae Kim
JYJong-Chan Youn
Jong-Chan Youn
HLHye Won Lee
Hye Won Lee
JOJaewon Oh
Jaewon Oh
JSJung-Woo Son
Jung-Woo Son
EJEun-Seok Jeon
Eun-Seok Jeon
Kim D, et al. J Korean Med Sci. 2024 May;39(19):e163. https://doi.org/10.3346/jkms.2024.39.e163

10 August 2022 in Nursing & Health Sciences
Verified
Journal Article
Closed access
HLHyewon Lee
Hyewon Lee
IJIhn Sook Jeong
Ihn Sook Jeong

31 December 2024 in Korean Journal of Healthcare-Associated Infection Control and Prevention
Verified
Journal Article
Open access
PDF file
HLHyewon Lee
Hyewon Lee
SGSuryeong Go
Suryeong Go
HOHong Sang Oh
Hong Sang Oh
Hyewon Lee, Suryeong Go, Hong Sang Oh. Korean J healthc assoc Infect Control Prev 2024;29:73-81. https://doi.org/10.14192/kjicp.2024.29.2.73

1 January 2024 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
BKByoungje Kim
Byoungje Kim
MKMin Seong Kim
Min Seong Kim
MKMi Jeong Kim
Mi Jeong Kim
JYJae Hyuck Yi
Jae Hyuck Yi
JPJin Hyuk Paek
Jin Hyuk Paek
KKKoo Jeong Kang
Koo Jeong Kang
김병제, et al. J Korean Soc Radiol. 2024 Nov;85(6):1157-1168. https://doi.org/10.3348/jksr.2023.0096